Tripelennamine 1% topical cream versus diphenhydramine 1% topical cream for the relief of histamine-induced itching: A proof-of-concept study in healthy adults.
Nornoo, A. O.; Maarsingh, H.
Show abstract
Introduction: There is an unmet need for effective topical anti-pruritic medications for acute itch, as there are only a few over-the-counter products that have a direct effect on itch. Tripelennamine is a first-generation antihistamine that would be useful in treating histamine-induced pruritus, however, supportive robust clinical data is lacking. Objectives: The efficacy of tripelennamine (TPA) compared to diphenhydramine (DPH) and a vehicle control cream base on histamine-induced pruritus was evaluated as the primary endpoint. Histamine-induced urticaria served as the secondary endpoint. Methods: Thirty-six healthy participants completed this single-center, double-blinded, placebo-controlled crossover clinical study. Following pretreatment with TPA1%, DPH 1% or vehicle control creams, histamine challenge occurred via iontophoresis and a visual analog scale (VAS) for pruritus was used to determine extent of itch (AUC-VAS), peak itch, and duration of itch. Results: Compared to the vehicle control, TPA reduced histamine-induced extent of itch (AUC-VAS), peak itch, and itch duration by 59%, 38% and 43%, respectively (p<0.01 all). DPH did not significantly affect these responses and TPA was superior in reducing extent of itch (48% reduction, p<0.05) and duration (38% shorter, p<0.05). TPA, but not DPH, also reduced histamine induced flare and wheal responses (secondary endpoints) by 53% and 27%, respectively. The reduction in flare responses by TPA was superior to that of DPH (45% reduction, p<0.05). Conclusion: TPA significantly attenuated histamine-induced pruritus and urticaria in a human histamine-challenge model and demonstrated greater efficacy than DPH. These findings provide strong evidence of the antipruritic activity of topical TPA and support further clinical investigation of TPA as a treatment for histaminergic itch and related dermatologic conditions.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Development of a Core Outcome Measure Instrument; “LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis 92%
- A randomised controlled trial of raw honey for the healing of ulcers in leprosy in Nigeria 91%
- Health-Related Quality of Life of Adults with Cutaneous Leishmaniasis at ALERT Hospital, Addis Ababa, Ethiopia 89%
Similar papers in this journal
- Effect of structural stability on endolysosomal degradation and T-cell reactivity of major shrimp allergen tropomyosin 89%
- Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma 86%
- Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis 86%
Similar papers in this journal
- Comparative Transcriptome Analysis of Acne vulgaris, Rosacea, and Hidradenitis Suppurativa Supports High Dose Dietary Zinc as a Therapeutic Agent 90%
- The vitamin A ester retinyl propionate has a unique metabolic profile and higher retinoid-related bioactivity over retinol and retinyl palmitate in human skin models. 89%
- RNA sequencing of a large number of psoriatic patients identifies 131 novel miRNAs and 11 miRNAs associated with disease severity 87%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.